STAT3 and cancer: Both atovaquone and pyrimethamine have previously been shown to be effective in murine xenotransplant models of STAT3-dependent cancers [13,14,15], and clinical trials using these drugs as STAT3 inhibitors, either alone or in combination with other agents, have commenced (ClinicalTrials.gov NCT03568994 and NCT01066663).